Protalix BioTherapeutics (PLX) Other Non Operating Income (2010 - 2026)

Protalix BioTherapeutics' Other Non Operating Income history runs 17 years deep, the most recent figure standing at $188000.0 for Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 55.13% year-over-year to $188000.0 in Q1 2026; TTM through Mar 2026 was $1.0 million, a 15.93% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 16.63% from the prior year.
• Other Non Operating Income retreated to $188000.0 in Q1 2026 per PLX's latest filing, from $265000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $813000.0 in Q2 2022 and bottomed at -$65000.0 in Q4 2022.
• The 5-year median for Other Non Operating Income is $265000.0 (2025), against an average of $304235.3.
• Biggest YoY gain for Other Non Operating Income was 535.16% in 2022; the steepest drop was 3150.0% in 2022.
• Year by year, Other Non Operating Income stood at -$65000.0 in 2022, then soared by 43.08% to -$37000.0 in 2023, then surged by 405.41% to $113000.0 in 2024, then surged by 134.51% to $265000.0 in 2025, then dropped by 29.06% to $188000.0 in 2026.
• Per Business Quant, the three latest PLX Other Non Operating Income figures stand at $188000.0 (Q1 2026), $265000.0 (Q4 2025), and $288000.0 (Q3 2025).